Qube Research & Technologies (QRT)’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-138,603
Closed -$2.55M 2621
2020
Q4
$2.55M Buy
138,603
+511
+0.4% +$9.31K 0.04% 526
2020
Q3
$2.53M Buy
+138,092
New +$2.32M 0.04% 565

Qube Research & Technologies (QRT)'s CBMG Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 138,603 shares — an estimated $2.55M sold.

Qube Research & Technologies (QRT) first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $2.55M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 138,603 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $2.55M.
  • Qube Research & Technologies (QRT) first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Cellular Biomedicine Group, Inc. position peaked at $2.55M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.